Erenumab For Treatment of Hemicrania Continua
Condition(s):Hemicrania ContinuaLast Updated:February 17, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Hemicrania ContinuaLast Updated:February 17, 2023Terminated
Condition(s):Migraine; Chronic Tension-Type Headache; Cluster Headache; Hemicrania ContinuaLast Updated:January 11, 2024Recruiting
Condition(s):Cluster Headache; Cluster Headaches and Other Trigeminal Autonomic Cephalgias; Paroxysmal Hemicrania; SUNCT; Hemicrania Continua; Trigeminal NeuralgiaLast Updated:November 28, 2023Recruiting
Condition(s):Migraine; Cluster Headache; Trigeminal Autonomic Cephalgia; Hemicrania Continua; Paroxysmal Hemicrania; SUNCT; Short-Lasting Unilateral Neuralgiform Headache With Conjunctival Injection and TearingLast Updated:November 28, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.